Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

CAFE Study - Cancer Patient Fracture Evaluation
A Multicenter, Prospective, Randomized, Controlled Study to Compare Balloon Kyphoplasty to Non-surgical Fracture Management in the Treatment of Painful, Acute Vertebral Body Compression Fractures in Cancer Patients
Status: Enrolling
Updated:  12/6/2017
St. Vincent's Hospital
mi
from
Fitzroy,
CAFE Study - Cancer Patient Fracture Evaluation
A Multicenter, Prospective, Randomized, Controlled Study to Compare Balloon Kyphoplasty to Non-surgical Fracture Management in the Treatment of Painful, Acute Vertebral Body Compression Fractures in Cancer Patients
Status: Enrolling
Updated: 12/6/2017
St. Vincent's Hospital
mi
from
Fitzroy,
Click here to add this to my saved trials
FREE Study - Fracture Reduction Evaluation
An International Multicentric, Multidisciplinary Prospective and Randomized Study to Compare Minimally Invasive Reduction and Fixation Using the KyphX System and Radiopaque PMMA Cement to Medical Therapy Alone for the Treatment of Painful, Acute Osteopenic Vertebral Body Compression Fractures
Status: Enrolling
Updated:  12/6/2017
University of Alabama
mi
from
Birmingham, AL
FREE Study - Fracture Reduction Evaluation
An International Multicentric, Multidisciplinary Prospective and Randomized Study to Compare Minimally Invasive Reduction and Fixation Using the KyphX System and Radiopaque PMMA Cement to Medical Therapy Alone for the Treatment of Painful, Acute Osteopenic Vertebral Body Compression Fractures
Status: Enrolling
Updated: 12/6/2017
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of California-Davis
mi
from
Sacramento, CA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Children'S Hospital
mi
from
Aurora, CO
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Children'S Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Child Neurology Center of Pensacola
mi
from
Pensacola, FL
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Child Neurology Center of Pensacola
mi
from
Pensacola, FL
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of Iowa Healthcare
mi
from
Iowa City, IA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of Iowa Healthcare
mi
from
Iowa City, IA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of Kansas Medical Centre
mi
from
Kansas City, KA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of Kansas Medical Centre
mi
from
Kansas City, KA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Children's Hospital Boston - Harvard Medical School
mi
from
Boston, MA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Children's Hospital Boston - Harvard Medical School
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Columbia University Medical School
mi
from
New York, NY
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Columbia University Medical School
mi
from
New York, NY
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Shriners Hospital for Children
mi
from
Portland, OR
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Shriners Hospital for Children
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Southwestern University
mi
from
Dallas, TX
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Southwestern University
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
University of Utah
mi
from
Salt Lake City, UT
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated:  12/6/2017
Royal Children's Hospital
mi
from
Parkville,
Phase 2b Study of PTC124 in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
A Phase 2b Efficacy and Safety Study of PTC124 in Subjects With Nonsense-Mutation-Mediated Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Status: Enrolling
Updated: 12/6/2017
Royal Children's Hospital
mi
from
Parkville,
Click here to add this to my saved trials
Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Status: Enrolling
Updated:  12/6/2017
Foundation for Orthopaedic Research and Education
mi
from
Temple Terrace, FL
Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Status: Enrolling
Updated: 12/6/2017
Foundation for Orthopaedic Research and Education
mi
from
Temple Terrace, FL
Click here to add this to my saved trials
Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Status: Enrolling
Updated:  12/6/2017
Atrium Medical Center
mi
from
Middletown, OH
Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Status: Enrolling
Updated: 12/6/2017
Atrium Medical Center
mi
from
Middletown, OH
Click here to add this to my saved trials
Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Status: Enrolling
Updated:  12/6/2017
Aurora Medical Group, Memorial Hospital of Burlington
mi
from
Burlington, WI
Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Status: Enrolling
Updated: 12/6/2017
Aurora Medical Group, Memorial Hospital of Burlington
mi
from
Burlington, WI
Click here to add this to my saved trials
Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Status: Enrolling
Updated:  12/6/2017
CHC - Les Cliniques Saint-Joseph
mi
from
Liege,
Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty
Status: Enrolling
Updated: 12/6/2017
CHC - Les Cliniques Saint-Joseph
mi
from
Liege,
Click here to add this to my saved trials
Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly
Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Impact of a Daily Dose of an Astaxanthin Formulation Alone and With Exercise Training on Skeletal Muscle Function in the Elderly
Status: Enrolling
Updated:  12/6/2017
Fred Hutchinson Cancer Research Center - Prevention Center
mi
from
Seattle, WA
Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly
Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Impact of a Daily Dose of an Astaxanthin Formulation Alone and With Exercise Training on Skeletal Muscle Function in the Elderly
Status: Enrolling
Updated: 12/6/2017
Fred Hutchinson Cancer Research Center - Prevention Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly
Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Impact of a Daily Dose of an Astaxanthin Formulation Alone and With Exercise Training on Skeletal Muscle Function in the Elderly
Status: Enrolling
Updated:  12/6/2017
University of Washington Medical Center
mi
from
Seattle, WA
Clinical Trial of Astaxanthin Formulation With Exercise in Sarcopenia Elderly
Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Impact of a Daily Dose of an Astaxanthin Formulation Alone and With Exercise Training on Skeletal Muscle Function in the Elderly
Status: Enrolling
Updated: 12/6/2017
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated:  12/6/2017
St. Mary's Spine Center
mi
from
San Francisco, CA
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated: 12/6/2017
St. Mary's Spine Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated:  12/6/2017
Neurological & Spine Associates
mi
from
Scarborough, ME
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated: 12/6/2017
Neurological & Spine Associates
mi
from
Scarborough, ME
Click here to add this to my saved trials
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated:  12/6/2017
Greater Baltimore Spine Care
mi
from
Timonium, MD
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated: 12/6/2017
Greater Baltimore Spine Care
mi
from
Timonium, MD
Click here to add this to my saved trials
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated:  12/6/2017
Neurological Specialist
mi
from
Norfolk, VA
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated: 12/6/2017
Neurological Specialist
mi
from
Norfolk, VA
Click here to add this to my saved trials
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated:  12/6/2017
University Hospital
mi
from
Madison, WI
Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®
Long-term Outcomes Among Patients With Lumbar Spinal Stenosis Treated With the X STOP® Interspinous Process Decompression System: Five-Year Follow-up of IDE Patient Cohorts
Status: Enrolling
Updated: 12/6/2017
University Hospital
mi
from
Madison, WI
Click here to add this to my saved trials
Reducing Falls With RENEW in Older Adults Who Have Fallen
Reducing Falls With RENEW in Older Adults Who Have Fallen
Status: Enrolling
Updated:  12/7/2017
Department of Physical Therapy, University of Utah
mi
from
Salt Lake City, UT
Reducing Falls With RENEW in Older Adults Who Have Fallen
Reducing Falls With RENEW in Older Adults Who Have Fallen
Status: Enrolling
Updated: 12/7/2017
Department of Physical Therapy, University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Sacramento, CA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
San Diego, CA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Brandon, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
DeLand, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Lakeland, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Ocala, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Orlando, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Columbus, GA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Smyrna, GA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Evansville, IN
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
North Dartmouth, MA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Jackson, MS
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Williamsville, NY
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Williamsville, NY
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Cincinnati, OH
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials